News
-
Data are no longer off-the-rack assets: They’re haute couture, a podcast presented by Pixacore
Creating a path forward through creative and strategic data-based decisions.
MM+M - Medical Marketing and Media, 08/30/2022
Clients
| Client | Start Year | End Year |
|---|---|---|
| Ultragenyx | 2022 | Current |
| Iovance | 2021 | Current |
| Novartis Pharmaceuticals | 2021 | Current |
| Janssen Biotech | 2021 | Current |
| ADC Theraputics | 2021 | Current |
| Fresenius Kabi | 2020 | Current |
| Intercept Pharmaceuticals | 2018 | Current |
| BMS | 2018 | Current |
| Bayer Medical | 2013 | Current |
| Bayer Commercial | 2013 | Current |
About
PIXACORE embarks on a bespoke journey of transformation. We guide brands to make creative, strategic, and technological decisions based on data and create personalized, go-to-market roadmaps. We empower them by listening, learning, and quickly adapting.
People
-
Michael Tanner
VP, Group Account Supervisor
Michael’s joins with over a decade of account service experience with particular focus on strategic recommendations, tactical planning and execution, and client partnership growth. With a breadth of pharma marketing experience that spans numerous populations, channels. and disease states (from oncology, PAH and HIV, to narcolepsy and sickle cell disease), Michael prefers to lead and problem solve collaboratively with teammates to ensure the best quality of work clients. -
Dhaval Parikh
Managing Director & President
Dhaval exhibits an entrepreneurial talent for quickly seeing past the noise to form solutions. For over 13 years, he has partnered with clients across several industries to provide business consulting, brand strategy, and digital guidance. In his 11 years as President of PIXACORE, Dhaval has effectively driven innovation for his clients and the agency. Collaborating with his Account, Technology, and Creative teams, Dhaval challenges the status quo to achieve excellence. With his financial acumen and partnership approach, Dhaval assures that both PIXACORE and its clients are grounded in decisions that are measurable and actionable. His brand focus has centered on neurologic and oncologic medicines. -
Sanjiv Mody
Founder and CEO
Sanjiv is a 25-year veteran of the interactive industry. His leadership, experience, insight, vision, and innovative approach help his clients, partners, and staff realize measurable success. His expertise is in providing tailored strategies and impactful solutions while accounting for success factors like business objectives, technology landscape, audience, and stakeholders. He has steered large organizations and multibillion-dollar brands to achieve greater efficiency and profitability by embracing and adapting technology to fit their needs.